Genolution Inc. (225220)

Overview

Genolution Inc. is a prominent entity in the biotechnology industry, rooted in Seoul, South Korea, since its establishment in 2006. This innovative company engages in the design, manufacture, and global distribution of in-vitro diagnostic (IVD) products. Genolution Inc. has carved a niche for itself in the field of molecular diagnostics, exploiting the potent capabilities of ribonucleic acid interference (RNAi) technology. The company's product line targets not just the healthcare sector but also ventures into dsRNA research instrumental in pest control applications, showcasing a versatile approach to biotechnological advancements. Its international operations enable a broad sphere of influence, contributing significantly to medical and scientific communities worldwide.

Products and Services

Genolution Inc. offers a wide range of products and services, each designed with precision to meet the diverse needs of its clientele. The essence of its innovations is summarized below:

• Nextractor: An advanced automatic extraction system pioneered by Genolution Inc., Nextractor stands out for its efficiency in isolating DNA or RNA from a variety of sample types. This technology simplifies and accelerates the preparatory steps in genetic analysis, benefiting laboratories with its versatility and ease of use.
• Extraction Kits: The company's arsenal includes a comprehensive array of extraction kits tailored for specific sample types and purposes. These encompass FFPE (formalin-fixed, paraffin-embedded), whole blood, buccal swab, RV (respiratory virus), TB/NTM (tuberculosis/nontuberculous mycobacteria), STD (sexually transmitted diseases), HPV (human papillomavirus), HBV (hepatitis B virus), and CMV/EBV (cytomegalovirus/Epstein–Barr virus) kits. Additionally, there are specialized kits for extracting genetic material from rice, plants, and cells, ensuring wide-ranging applicability in genetic research and diagnostics.
• siRNA/shRNA Synthesis Service: Genolution Inc. offers custom synthesis services for small interfering RNA (siRNA) and short hairpin RNA (shRNA). These molecules are crucial in gene silencing applications, allowing researchers to effectively inhibit gene expression in various organisms. This service is indispensable in functional genomics, target validation, and therapeutic research, offering clients tailored solutions to meet their experimental requirements.
• Long dsRNA Synthesis Service: Building on its expertise in RNA technologies, the company also provides synthesis services for long double-stranded RNA (dsRNA). This is particularly useful in gene expression inhibition by introducing dsRNA into organisms, a method extensively used in pest control research and therapeutic applications. This service underscores Genolution Inc.'s commitment to supporting advanced studies in RNA interference and its practical applications in improving health and food safety.